Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2023-10-31 15:30:19
Oslo, Norway, October 31, 2023 - Primary insider Michael Engsig, Chief Executive
Officer of Nykode Therapeutics ASA, has today acquired 9,850 shares in Nykode
Therapeutics ASA at a price of NOK 17.10 per share.
Please see further details in the attached document.